Symptoms may include coma; confusion; disorientation; seizures. If you use insulin or take diabetes medicine by mouth, ask your doctor if your dose synthroid substitute to be changed when you start using levothyroxine. Levothyroxine should not be used to treat obesity or weight problems. Therefore, it is recommended that patients receiving levothyroxine sodium be given the minimum dose necessary to achieve the desired clinical and biochemical response. Abbott Laboratories North Chicago, IL 60064, U.S.A. Call your doctor at once if you have any of these serious side effects: headache; synthroid substitute problems (insomnia); nervous or irritable synthroid substitute fever, hot flashes, sweating; changes in your menstrual periods; appetite changes, weight changes; Less serious Synthroid side effects may include mild hair loss. Therefore, it is recommended that patients receiving levothyroxine sodium be given the minimum dose necessary to achieve the desired clinical and biochemical response. 6 FD&C RED NO.
synthroid and oatmeal interactions
Discuss any possible synthroid substitute to your baby. How should I take Synthroid? Take Synthroid exactly as prescribed by your doctor. Ketamine Concurrent use may produce marked hypertension and tachycardia; cautious administration to patients receiving thyroid hormone therapy is recommended. The dose of Synthroid that is adequate to achieve these goals depends on a variety of factors including the patient's age, body weight, cardiovascular status, concomitant medical conditions, including pregnancy, concomitant medications, and the specific nature of the condition being treated (see WARNINGS and PRECAUTIONS). 6 Aluminum Lake 112 D&C Red No. A 38-year-old female experienced with severe hypothyroidism experienced myxedema coma and cardiac ischemia coincident with levothyroxine therapy. 30 Product Characteristics Color PURPLE (Lilac) Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;175 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-7070-13 100 TABLET In 1 BOTTLE None 2 0074-7070-71 28 TABLET In 1 BOX None 3 0074-7070-19 1000 TABLET In 1 BOTTLE None Marketing Information Marketing Category Application Number synthroid substitute Monograph Citation Marketing synthroid substitute Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-7148 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 200 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C RED NO. Notify your physician or dentist that you are taking Synthroid prior to any surgery. Patients with coronary artery disease who are receiving levothyroxine therapy should be monitored closely during surgical synthroid substitute since the possibility of precipitating cardiac arrhythmias may be greater in those treated with synthroid substitute Where can I get more information? Your pharmacist can provide more information about levothyroxine. The major pathway of thyroid hormone metabolism is through sequential deiodination. The synthetic T4 in Synthroid synthroid substitute identical to that produced naturally by the human thyroid gland. She underwent coronary artery bypass grafting, with subsequent improvement in coronary perfusion. They include the following: General fatigue, increased appetite, weight loss, heat intolerance, fever, synthroid substitute sweating; Central nervous system headache, hyperactivity, nervousness, anxiety, irritability, emotional lability, insomnia; Musculoskeletal tremors, muscle weakness; Cardiovascular palpitations, tachycardia, arrhythmias, increased pulse and blood pressure, heart failure, angina, myocardial infarction, cardiac arrest; Respiratory dyspnea; Gastrointestinal diarrhea, vomiting, abdominal cramps and elevations in liver synthroid substitute tests; Dermatologic synthroid substitute loss, flushing; Endocrine decreased bone mineral density; Reproductive menstrual irregularities, impaired fertility. It may take several weeks before your body starts to respond to this medication. In fact, your doctor will test you regularly and may increase your dose. Cardiovascular side effects synthroid substitute included symptoms of palpitations, hypertension, tachycardia, and angina which may be exacerbated in patients with underlying cardiovascular disorders.
Patients receiving Synthroid for appropriate clinical indications should be titrated to the lowest effective replacement dose. 2 Product Characteristics Color BLUE Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;150 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-7069-13 100 TABLET In 1 BOTTLE None 2 0074-7069-71 28 TABLET In 1 BOX None 3 0074-7069-19 1000 TABLET In 1 BOTTLE None 4 0074-7069-11 10 BLISTER PACK In 1 BOX, UNIT-DOSE contains a BLISTER PACK 4 10 TABLET In 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0074-7069-11) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-7070 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength synthroid substitute SODIUM (LEVOTHYROXINE) synthroid substitute SODIUM 175 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE synthroid substitute STEARATE synthroid substitute POVIDONE TALC FD&C BLUE NO. The increased bone resorption may be associated with increased serum levels and urinary excretion of calcium and phosphorous, elevations in bone alkaline phosphatase and suppressed serum parathyroid hormone levels. 1 synthroid substitute Lake, FD&C Yellow No. The metabolic actions of thyroid hormones include augmentation of cellular respiration and thermogenesis, as well as metabolism of proteins, carbohydrates and lipids. Long-term aminoglutethimide therapy may minimally decrease T4 and T3 levels and increase TSH, although all values remain within normal limits in most patients. Patients with Nontoxic Diffuse Goiter or Nodular Thyroid Disease Exercise caution when administering levothyroxine to patients with synthroid substitute diffuse goiter or nodular thyroid disease in order to prevent precipitation of thyrotoxicosis (see WARNINGS ). Contact your doctor if hair loss is severe or persistent. Pharmacokinetics Absorption Absorption of orally administered T4 from the gastrointestinal (GI) tract ranges from 40% to 80%. Inadequate levothyroxine synthroid substitute will produce or fail to ameliorate the signs and symptoms of hypothyroidism. Provide respiratory support as needed; control congestive synthroid substitute failure and arrhythmia; control fever, hypoglycemia, and fluid loss as necessary. Musculoskeletal Musculoskeletal side effects have included an increase risk of osteoporosis. Pharmacokinetics Absorption Absorption of orally administered T4 from the gastrointestinal (GI) tract ranges from 40% to 80%.